Cargando…

Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients

PURPOSE: Change in mammographic density has been suggested to be a proxy of tamoxifen response. We investigated the effect of additional adjuvant systemic therapy and CYP2D6 activity on MD change in a cohort of tamoxifen-treated pre- and postmenopausal breast cancer patients. METHODS: Swedish breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thorén, Linda, Eriksson, Mikael, Lindh, Jonatan D., Czene, Kamila, Bergh, Jonas, Eliasson, Erik, Hall, Per, Margolin, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558195/ https://www.ncbi.nlm.nih.gov/pubmed/34570302 http://dx.doi.org/10.1007/s10549-021-06386-2

Ejemplares similares

Time to Mammographic Density Decrease After Exposure to Tamoxifen
por: Bäcklund, Magnus, et al.
Publicado: (2022)

CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Prognosis in Patients With Breast Cancer
por: He, Wei, et al.
Publicado: (2020)

Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer
por: Eriksson, Louise, et al.
Publicado: (2019)

Adherence to endocrine therapy in early breast cancer in relation to Cytochrome P450 2D6 genotype: a comparison between pharmacy dispensation data and medical records
por: Thorén, Linda, et al.
Publicado: (2023)

Impairment of endoxifen formation in tamoxifen‐treated premenopausal breast cancer patients carrying reduced‐function CYP2D6 alleles
por: Thorén, Linda, et al.
Publicado: (2020)

Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial
por: Eriksson, Mikael, et al.
Publicado: (2021)

Use of Low-Dose Tamoxifen to Increase Mammographic Screening Sensitivity in Premenopausal Women
por: Eriksson, Mikael, et al.
Publicado: (2021)

Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment
por: Li, Jingmei, et al.
Publicado: (2013)

Determinants of Mammographic Density Change
por: Azam, Shadi, et al.
Publicado: (2019)

Hormonal determinants of mammographic density and density change
por: Gabrielson, Marike, et al.
Publicado: (2020)

A comprehensive tool for measuring mammographic density changes over time
por: Eriksson, Mikael, et al.
Publicado: (2018)

Mammographic density and survival in interval breast cancers
por: Eriksson, Louise, et al.
Publicado: (2013)

Possible influence of mammographic density on local and locoregional recurrence of breast cancer
por: Eriksson, Louise, et al.
Publicado: (2013)

Predictors of mammographic microcalcifications
por: Azam, Shadi, et al.
Publicado: (2020)

Identification of two novel mammographic density loci at 6Q25.1
por: Brand, Judith S, et al.
Publicado: (2015)

Topical Endoxifen for Mammographic Density Reduction—A Randomized Controlled Trial
por: Bäcklund, Magnus, et al.
Publicado: (2022)

Influence of Lifestyle Factors on Mammographic Density in Postmenopausal Women
por: Brand, Judith S., et al.
Publicado: (2013)

Influence of mammographic density and compressed breast thickness on true mammographic sensitivity: a cohort study
por: Strandberg, Rickard, et al.
Publicado: (2023)

Mammographic microcalcifications and risk of breast cancer
por: Azam, Shadi, et al.
Publicado: (2021)

Mammographic features are associated with cardiometabolic disease risk and mortality
por: Grassmann, Felix, et al.
Publicado: (2021)

Localized mammographic density is associated with interval cancer and large breast cancer: a nested case-control study
por: Strand, Fredrik, et al.
Publicado: (2019)

Background risk of breast cancer and the association between physical activity and mammographic density
por: Trinh, Thang, et al.
Publicado: (2015)

Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors
por: Yang, Haomin, et al.
Publicado: (2020)

Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density
por: Byström, Sanna, et al.
Publicado: (2018)

Mammographic density and molecular subtypes of breast cancer
por: Eriksson, L, et al.
Publicado: (2012)

High-throughput mammographic-density measurement: a tool for risk prediction of breast cancer
por: Li, Jingmei, et al.
Publicado: (2012)

Common genetic variation and novel loci associated with volumetric mammographic density
por: Brand, Judith S., et al.
Publicado: (2018)

Change of mammographic density predicts the risk of contralateral breast cancer - a case-control study
por: Sandberg, Maria EC, et al.
Publicado: (2013)

Studying the association between longitudinal mammographic density measurements and breast cancer risk: a joint modelling approach
por: Illipse, Maya, et al.
Publicado: (2023)

Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years
por: Brentnall, Adam R., et al.
Publicado: (2020)

Long-term exposure to insulin and volumetric mammographic density: observational and genetic associations in the Karma study
por: Borgquist, Signe, et al.
Publicado: (2018)

Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer
por: Matikas, Alexios, et al.
Publicado: (2017)

Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer
por: Li, Jingmei, et al.
Publicado: (2010)

Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach
por: Andersson, Therese M -L, et al.
Publicado: (2017)

Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study
por: van Nes, J. G. H., et al.
Publicado: (2012)

Association of infertility and fertility treatment with mammographic density in a large screening-based cohort of women: a cross-sectional study
por: Lundberg, Frida E., et al.
Publicado: (2016)

Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants
por: Evans, D. Gareth R., et al.
Publicado: (2019)

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects
por: Dezentjé, V. O., et al.
Publicado: (2015)

Area and Volumetric Density Estimation in Processed Full-Field Digital Mammograms for Risk Assessment of Breast Cancer
por: Cheddad, Abbas, et al.
Publicado: (2014)

Mammographic density. Measurement of mammographic density
por: Yaffe, Martin J
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_5agauhrv2v55pjlgctqqf30dhd